Vascular insulin/insulin-like growth factor-1 resistance in female obese Zucker rats

Metabolism: Clinical and Experimental

Volumn 50, Issue 5, 2001, Pages 607-612

  Walsh, M F ^b   Ali, S S ^b   Sowers, J R ^a  

^a SUNY DOWNSTATE MEDICAL CENTER   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CHOLERA TOXIN; GLUCOSE; GUANINE NUCLEOTIDE BINDING PROTEIN; INHIBITORY GUANINE NUCLEOTIDE BINDING PROTEIN; INSULIN; INSULIN RECEPTOR; ISOPRENALINE; PERTUSSIS TOXIN; PHENYLEPHRINE; PROTEIN TYROSINE KINASE; SOMATOMEDIN C; STIMULATORY GUANINE NUCLEOTIDE BINDING PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; AORTA; ARTICLE; BLOOD VESSEL REACTIVITY; CONTROLLED STUDY; DIABETES MELLITUS; ENDOTHELIUM; ENZYME ACTIVITY; FEMALE; GLUCOSE TRANSPORT; INCUBATION TIME; INSULIN RESISTANCE; MUSCLE CONTRACTILITY; MUSCLE RELAXATION; NONHUMAN; OBESITY; PRIORITY JOURNAL; PROTEIN INTERACTION; RAT; RECEPTOR BINDING; SYSTOLIC BLOOD PRESSURE; VASCULARIZATION; VASOMOTOR REFLEX;

EID: 0009805746     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1053/meta.2001.21701     Document Type: Article

References (39)

1. 1. Garcia MJ, McNamara PM, Gordon T, et al: Morbidity and mortality in diabetics in the Framingham population: Sixteen-year follow-up study. Diabetes Care 13:631-654, 1990
2. 2. Barrett-Connor E, Cohn BA, Wingard DL, et al: Why is diabetes mellitus a stronger risk factor for fatal ischemic heart disease in women than in men? JAMA 265:627-631, 1991
3. 3. Peuler JD, Johnson B, Phare S, et al: Sex-specific effects of an insulin secretagogue in stroke-prone hypertensive rats. Hypertension 22:214-220, 1993
4. 4. Sowers JR: Diabetes mellitus and cardiovascular disease in women. Arch Intern Med 158:617-621, 1997
5. 5. Jacobs RJ, Sherwin RS, Greenwalt K, et al: Simultaneous IGF-I and insulin resistance in the obese Zucker rat. Diabetes 41:691-697, 1992
6. 6. Liu S, Baracos VE, Quinney HA, et al: Parallel insulin-like growth factor I and insulin resistance in muscles of rats fed a high fat diet. Endocrinology 136:3318-3324, 1995
7. 7. Zemel MB, Feuler JD, Sowers JR, et al: Hypertension in insulin-resistant Zucker obese rats is independent of neural support. Am J Physiol 262:E368-E371, 1992
8. 8. Alonso-Galicia M, Brands MW, Zappe DH, et al: Hypertension in obese Zucker rats. Role of angiotensin II and adrenergic activity. Hypertension 28:1047-1054, 1996
9. 2+ handling in the aorta of Zucker obese rats with insulin resistance. Diabetes 45:S55-S58, 1996
10. 10. Standley PR, Ali SS, Bapna C, et al: Increased cytosolic calcium responses in arterial smooth muscle from Zucker rats. Endocrinology 133:1693-1699, 1993
11. 11. Standley PR, Rose KA, Sowers JR: Increased basal arterial smooth muscle glucose transport in the Zucker rat. Am J Hypertens 8:45-52, 1995
12. 12. Hadcock JR, Port JD, Gelman MS, et al: Cross-talk between tyrosine kinase and G-protein-linked receptors. Phosphorylation of B2 adrenergic receptors in response to insulin. J Biol Chem 267:26017-26022, 1992
13. 13. Rothenberg PL, Kahn CR: Insulin inhibits pertussis toxin catalyzed ADP-ribosylation of G-proteins. Evidence for a novel interaction between insulin receptors and G proteins. J Biol Chem 263:15546-15552, 1988
14. 14. Luttrell LM, van Biesen T, Hawes BE et al: G-beta gamma subunits mediate mitogen-activated protein kinase activation by the tyrosine kinase IGF-I receptor. J Biol Chem 270:16495-16498, 1995
15. 15. Delafontaine P, Anwar A, Lou H, et al: G-protein coupled and tyrosine kinase receptors: Evidence that activation of the IGF-I receptor is required for thrombin-induced mitogenesis of rat aortic smooth muscle cells. J Clin Invest 97:139-145, 1996
16. 16. Green A, Walters DJA, Belt SE: Insulin resistance in adipocytes after downregulation of Gi subtypes. Am J Physiol 273:E254-E261, 1997
17. 2. J Biol Chem 272:10135-10143, 1997
18. 2. Nature 379:840-844, 1996
19. 1-2 in vivo mimics insulin action. J Mol Med 75:283-289, 1997
20. 20. Lembo G, Laccarin G, Vecchione C, et al: Insulin modulation of an endothelial nitric oxide component present in the alpha-2 and beta-adrenergic response in the human forearm. J Clin Invest 100:2007-2014, 1997
21. 21. Gos R, Bockowski KR, Feldman RD: Human insulin-mediated enhancement of vascular B-adrenergic responsiveness. Hypertension 23:551-555, 1994
22. 22. Walsh MF, Barazi M, Pete G, et al: IGF-I diminishes in vivo and in vitro vascular reactivity: Role of nitric oxide. Endocrinology 137: 1798-1803, 1996
23. 23. Dominguez LJ, Davidoff AJ, Srinivas PR, et al: Effects of metformin on tyrosine kinase activity, glucose transport and intracellular calcium in rat vascular smooth muscle. Endocrinology 137:113-121, 1996
24. 24. Turner NC, White P: Effects of streptozotocin-induced diabetes on vascular reactivity in genetically hyperinsulinaemic obese Zucker rats. J Cardiovasc Pharmacol 27:884-890, 1996
25. 25. Zanchi A, Delacretaz E, Taleb V, et al: Endothelial function of the mesenteric arteriole and mechanical behaviour of the carotid artery in rats with insulin resistance and hypercholesterolaemia. J Hypertens 13:1463-1470, 1995
26. 26. Walker AB, Dores J, Buckingham RE, et al: Impaired insulin-induced attenuation of noradrenaline-mediated vasoconstriction in insulin-resistant obese Zucker rats. Clin Sci 93:235-241, 1997
27. 27. Kam KI, Paffendorf M, van Zwieten PA: Pharmacodynamic behaviour of isolated vessels obtained from hypertensive-diabetic rats. Fundam Clin Pharmacol 10:329-336, 1996
28. 28. Ciaraldi TP, Maisel A: Role of guanine nucleotide regulatory proteins in insulin stimulation of glucose transport. Biochem J 264: 389-396, 1989
29. i-2 in hepatocytes from lean (Fa/Fa) and obese (fa/fa) Zucker rats. Eur J Biochem 192:537-542, 1990
30. i in adipocyte plasma membranes of genetically diabetic (db/db) mice. Am J Physiol 262:C121-C129, 1992
31. ai) in spontaneously hypertensive rats. Am J Hypertens 4:840-843, 1991
32. 32. Asano M, Masuzawa K, Matsuda T, et al: Reduced function of the stimulatory GTP-binding protein in beta adrenoreceptor-adenylyl cyclase system of femoral arteries isolated from spontaneously hypertensive rats. J Pharmacol Exp Ther 246:709-718, 1988
33. 33. Iranami H, Hatano Y, Tsukiyama Y, et al: A beta-adrenoreceptor agonist evokes a nitric-oxide-cGMP relaxation mechanism modulated by adeylyl cyclase in rat aorta. Anesthesiology 85:1129-1139, 1996
34. 34. Eckly-Michel A, Martin V, Lugnier C: Involvement of cyclic nucleotide-dependent protein kinases in cyclic AMP-mediated vasorelaxation. Br J Pharmacol 122:158-164, 1997
35. 35. Zeng G, Quon MJ: Insulin-stimulated production of nitric oxide is inhibited by Wortmannin. Direct measurement in vascular endothelial cells that are also involved in glucose metabolism. J Clin Invest 98:894-898, 1996
36. 36. Ahmad F, Goldstein BJ: Increased abundance of specific skeletal muscle protein tyrosine phosphatases in a genetic model of insulin-resistant obesity and diabetes mellitus. Metabolism 44:1175-1184, 1995
37. 2 adrenergic vasorelaxation by a pertussis toxin mechanism. Hypertension 30:128-134, 1997
38. 38. Anai M, Funaki M, Ogihara T, et al: Altered expression levels and impaired steps in the pathway to P13 kinase activation via insulin receptor substrates 1 and 2 in Zucker fatty rats. Diabetes 47:13-23, 1998
39. 39. Kolter T, Uphues 1, Eckel 1: Molecular analysis of insulin resistance in isolated ventricular cardiomyocytes of obese Zucker rats. Am J Physiol 273:59-67, 1997